S&P 500   3,390.55 (+0.60%)
DOW   29,373.58 (+0.48%)
QQQ   237.15 (+1.03%)
AAPL   324.44 (+1.71%)
FB   217.26 (-0.25%)
MSFT   187.46 (+0.12%)
GOOGL   1,528.70 (+0.61%)
AMZN   2,181.50 (+1.20%)
CGC   21.81 (-0.59%)
NVDA   310.50 (+4.70%)
BABA   221.90 (+0.63%)
GE   12.91 (+1.26%)
TSLA   938.52 (+9.33%)
AMD   58.81 (+3.37%)
T   38.44 (+0.47%)
ACB   1.70 (+3.65%)
F   8.02 (-0.50%)
NFLX   387.92 (+0.04%)
BAC   34.73 (+1.31%)
DIS   140.80 (+1.19%)
GILD   66.84 (-0.25%)
S&P 500   3,390.55 (+0.60%)
DOW   29,373.58 (+0.48%)
QQQ   237.15 (+1.03%)
AAPL   324.44 (+1.71%)
FB   217.26 (-0.25%)
MSFT   187.46 (+0.12%)
GOOGL   1,528.70 (+0.61%)
AMZN   2,181.50 (+1.20%)
CGC   21.81 (-0.59%)
NVDA   310.50 (+4.70%)
BABA   221.90 (+0.63%)
GE   12.91 (+1.26%)
TSLA   938.52 (+9.33%)
AMD   58.81 (+3.37%)
T   38.44 (+0.47%)
ACB   1.70 (+3.65%)
F   8.02 (-0.50%)
NFLX   387.92 (+0.04%)
BAC   34.73 (+1.31%)
DIS   140.80 (+1.19%)
GILD   66.84 (-0.25%)
S&P 500   3,390.55 (+0.60%)
DOW   29,373.58 (+0.48%)
QQQ   237.15 (+1.03%)
AAPL   324.44 (+1.71%)
FB   217.26 (-0.25%)
MSFT   187.46 (+0.12%)
GOOGL   1,528.70 (+0.61%)
AMZN   2,181.50 (+1.20%)
CGC   21.81 (-0.59%)
NVDA   310.50 (+4.70%)
BABA   221.90 (+0.63%)
GE   12.91 (+1.26%)
TSLA   938.52 (+9.33%)
AMD   58.81 (+3.37%)
T   38.44 (+0.47%)
ACB   1.70 (+3.65%)
F   8.02 (-0.50%)
NFLX   387.92 (+0.04%)
BAC   34.73 (+1.31%)
DIS   140.80 (+1.19%)
GILD   66.84 (-0.25%)
S&P 500   3,390.55 (+0.60%)
DOW   29,373.58 (+0.48%)
QQQ   237.15 (+1.03%)
AAPL   324.44 (+1.71%)
FB   217.26 (-0.25%)
MSFT   187.46 (+0.12%)
GOOGL   1,528.70 (+0.61%)
AMZN   2,181.50 (+1.20%)
CGC   21.81 (-0.59%)
NVDA   310.50 (+4.70%)
BABA   221.90 (+0.63%)
GE   12.91 (+1.26%)
TSLA   938.52 (+9.33%)
AMD   58.81 (+3.37%)
T   38.44 (+0.47%)
ACB   1.70 (+3.65%)
F   8.02 (-0.50%)
NFLX   387.92 (+0.04%)
BAC   34.73 (+1.31%)
DIS   140.80 (+1.19%)
GILD   66.84 (-0.25%)
Log in

Hemostemix News Headlines (CVE:HEM)

C$0.01
0.00 (0.00 %)
(As of 02/19/2020 11:31 AM ET)
Today's Range
C$0.01
Now: C$0.01
C$0.01
50-Day Range
C$0.01
MA: C$0.01
C$0.02
52-Week Range
C$0.01
Now: C$0.01
C$0.08
Volume180,000 shs
Average Volume368,742 shs
Market CapitalizationC$3.01 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Hemostemix (CVE HEM) News Headlines

Source:
DateHeadline
Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate UpdateHemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update
www.globenewswire.com - February 10 at 12:58 PM
Hemostemix Provides Corporate Update and ClarificationHemostemix Provides Corporate Update and Clarification
www.benzinga.com - January 27 at 6:15 AM
BRIEF-Hemostemix Announces Private PlacementBRIEF-Hemostemix Announces Private Placement
www.msn.com - January 2 at 4:34 PM
Hemostemix Announces Private PlacementHemostemix Announces Private Placement
www.globenewswire.com - January 2 at 4:34 PM
Hemostemix Announces Appointment of DirectorHemostemix Announces Appointment of Director
www.globenewswire.com - November 29 at 4:38 PM
Hemostemix Announces Director ResignationHemostemix Announces Director Resignation
finance.yahoo.com - November 22 at 10:56 PM
BRIEF-Hemostemix Says Kyle Makofka Has Resigned As CEOBRIEF-Hemostemix Says Kyle Makofka Has Resigned As CEO
www.msn.com - November 20 at 8:55 AM
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular SurgeryHemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
www.nasdaq.com - July 3 at 11:12 AM
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical TrialHemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
www.nasdaq.com - June 28 at 11:00 AM
Hemostemix Announces Resignation of CFOHemostemix Announces Resignation of CFO
www.nasdaq.com - June 26 at 11:23 AM
Hemostemix Announces Convertible Debenture FinancingHemostemix Announces Convertible Debenture Financing
www.globenewswire.com - April 15 at 9:14 AM
Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical TrialHemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
www.globenewswire.com - April 9 at 12:55 PM
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDAHemostemix Announces Submission of Orphan Drug Designation Application to the FDA
globenewswire.com - February 4 at 9:04 AM
Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical TrialHemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial
globenewswire.com - January 3 at 11:01 AM
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel